ASX Announcement

Type C Meeting granted by FDA for Phelan-McDermid syndrome

Published: 07/02/25, 08:14am (AEST)1 pages
Neuren Pharmaceuticals
NEU:ASXHealthcare

Recent NEU Announcements

Price Sensitive only